Changes in Antigen Carbohydrate 125 in Patients Receiving Dapagliflozin following an Admission for Acute Heart Failure

Changes in Antigen Carbohydrate 125 in Patients Receiving Dapagliflozin following an Admission for Acute Heart Failure

Introduction: Antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload and inflammation in acute heart failure (AHF). We aimed to evaluate the influence of dapagliflozin on CA125 levels within the first weeks after discharge and whether CA125 changes were related to 6-mon...

Full description

Saved in:
Bibliographic Details
Main Authors: Gema Miñana, Rafael de la Espriella, Miguel Lorenzo-Hernández, Enrique Rodriguez-Borja, Anna Mollar, Patricia Palau, Agustin Fernández-Cisnal, Ernesto Valero, Arturo Carratalá, Enrique Santas, Vicent Bodi, Juan Sanchis, Antoni Bayés-Genís, Eduardo Nuñez, Julio Nuñez
Format: Article
Language:English
Published: Karger Publishers 2025-01-01
Series:Cardiorenal Medicine
Online Access:https://karger.com/article/doi/10.1159/000543417
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://karger.com/article/doi/10.1159/000543417

Similar Items